death from semaglutide The weight-loss drug Wegovy lowered heart attack risk in a large trial Every researcher on a key

Mistake 8: losing track of the reconstitution date If you cannot remember when you reconstituted the vial, you cannot know if you are within the 28-day use window

You can read the full article at Recent research suggests a possible connection between Attention-Deficit/Hyperactivity Disorder (ADHD) and obesity

Anyone who has followed the conversation around GLP-1 medications knows the challenge: what happens when treatment stops

PATIENTS with systemic lupus erythematosus (SLE) and Type 2 diabetes (T2D) had significantly lower cardiovascular, kidney, and mortality risks when treated with GLP-1 receptor agonists (GLP-1RA) compared to DPP-4 inhibitors, a recent study found